Margaret E. Gatti‐Mays

Margaret E. Gatti-Mays' research centers on breast cancer treatment, particularly triple-negative and hormone receptor-positive subtypes, with a strong focus on immunotherapy (drugs that help the immune system fight cancer) and immune checkpoint inhibitors. Her work spans clinical trials testing new drug combinations, biomarker discovery to predict treatment response, and studies of treatment side effects such as immune-related adverse events and antibody-drug conjugate toxicities. She also investigates communication issues around cancer, including social media misinformation about breast cancer treatment.

Publication output grew substantially from 2017 to a peak in 2023, followed by a modest decline through 2025, though annual output remains well above early-decade levels.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026